CSNK2A1 and viral infectious disease: Since CKII has been implicated in many diseases and viral infection [32], numerous inhibitors targeting this kinase have been developed [33] and both DMAT and TBCA that were used in this study are TBB-derived, ATP-competitive CKII inhibitors (Fig. 6A).